TR200704370T2 - Göz, kulak ve burun tedavisi için antibiyotik bileşimler - Google Patents

Göz, kulak ve burun tedavisi için antibiyotik bileşimler

Info

Publication number
TR200704370T2
TR200704370T2 TR2007/04370T TR200704370T TR200704370T2 TR 200704370 T2 TR200704370 T2 TR 200704370T2 TR 2007/04370 T TR2007/04370 T TR 2007/04370T TR 200704370 T TR200704370 T TR 200704370T TR 200704370 T2 TR200704370 T2 TR 200704370T2
Authority
TR
Turkey
Prior art keywords
treatment
nose
ear
eye
compositions
Prior art date
Application number
TR2007/04370T
Other languages
English (en)
Turkish (tr)
Original Assignee
Alcon Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26799441&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200704370(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Laboratories, Inc. filed Critical Alcon Laboratories, Inc.
Publication of TR200704370T2 publication Critical patent/TR200704370T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TR2007/04370T 1998-09-30 1999-09-29 Göz, kulak ve burun tedavisi için antibiyotik bileşimler TR200704370T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10250498P 1998-09-30 1998-09-30
US10250698P 1998-09-30 1998-09-30

Publications (1)

Publication Number Publication Date
TR200704370T2 true TR200704370T2 (tr) 2007-11-21

Family

ID=26799441

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2007/04370T TR200704370T2 (tr) 1998-09-30 1999-09-29 Göz, kulak ve burun tedavisi için antibiyotik bileşimler
TR2001/00883T TR200100883T2 (tr) 1998-09-30 1999-09-29 Göz, kulak ve burun tedavisi için antibiyotik bileşimler

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2001/00883T TR200100883T2 (tr) 1998-09-30 1999-09-29 Göz, kulak ve burun tedavisi için antibiyotik bileşimler

Country Status (18)

Country Link
EP (5) EP1117401B1 (OSRAM)
JP (5) JP2002525317A (OSRAM)
KR (1) KR101463243B1 (OSRAM)
CN (2) CN1184968C (OSRAM)
AR (2) AR020661A1 (OSRAM)
AT (2) ATE501732T1 (OSRAM)
AU (1) AU762827B2 (OSRAM)
BR (1) BRPI9914151B1 (OSRAM)
CA (3) CA2774207A1 (OSRAM)
CY (3) CY1111404T1 (OSRAM)
DE (2) DE69943287D1 (OSRAM)
DK (5) DK2269602T3 (OSRAM)
ES (4) ES2519190T3 (OSRAM)
HK (1) HK1038691B (OSRAM)
PT (5) PT2796138T (OSRAM)
TR (2) TR200704370T2 (OSRAM)
TW (1) TWI222361B (OSRAM)
WO (1) WO2000018386A2 (OSRAM)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
DE19937115A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
DE19937116A1 (de) 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
CN1158994C (zh) 1999-09-24 2004-07-28 爱尔康公司 含环丙沙星和地塞米松的局部悬浮制剂
DE19962470A1 (de) * 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
WO2001089495A2 (en) * 2000-05-19 2001-11-29 Alcon Laboratories, Inc. Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose
AU2001276928A1 (en) 2000-07-26 2002-02-05 Alcon Universal Ltd. Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone
JPWO2002040028A1 (ja) * 2000-11-16 2004-03-18 わかもと製薬株式会社 抗菌ゲル化点眼剤
US7025958B2 (en) 2000-12-20 2006-04-11 Alcon, Inc. Use of amidoamines to treat or prevent acanthamoeba and fungal infections
WO2002049627A2 (en) * 2000-12-20 2002-06-27 Alcon, Inc. Antifungal compositions containing an antibiotic and one or more amidoamines
ES2250739T3 (es) 2001-09-21 2006-04-16 Alcon, Inc. Metodo para tratar infecciones del oido medio.
US7220431B2 (en) 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
BRPI0413964B8 (pt) 2003-09-10 2021-05-25 Kyorin Seiyaku Kk ácido derivado do ácido carboxílico quinolona, sua composição e agente antibacterial
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
WO2006029074A2 (en) * 2004-09-03 2006-03-16 Piedmont Pharmaceuticals, Llc Methods for transmembrane treatment and prevention of otitis media
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
KR20070089222A (ko) * 2004-12-10 2007-08-30 알콘, 인코퍼레이티드 귀 감염을 치료하기 위한 조성물
CN101317847B (zh) * 2007-06-06 2010-10-13 深圳市瑞谷医药技术有限公司 一种眼用或耳鼻用药物组合物及其用途
TWI544934B (zh) * 2008-06-09 2016-08-11 愛爾康研究有限公司 含有氟喹諾酮抗生素藥物之經改良藥學組成物
AU2010266120B2 (en) * 2009-07-02 2014-02-06 Curofin Pharma Gmbh Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections
KR20180027611A (ko) * 2010-01-07 2018-03-14 리전츠 오브 더 유니버스티 오브 미네소타 목시플록사신을 귀에 도포하기 위한 방법 및 조성물
WO2013085769A1 (en) 2011-12-06 2013-06-13 Alcon Research, Ltd. Cellulosic gel composition with improved viscosity stability
RU2472507C1 (ru) * 2012-02-01 2013-01-20 Закрытое акционерное общество "Брынцалов-А" Водный состав на основе моксифлоксацина для парентерального введения
US9504691B2 (en) * 2012-12-06 2016-11-29 Alcon Research, Ltd. Finafloxacin suspension compositions
US20160279055A1 (en) 2013-07-22 2016-09-29 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
US20150164882A1 (en) 2013-07-22 2015-06-18 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
CN104224802B (zh) * 2014-09-19 2017-12-12 南京优科生物医药研究有限公司 一种盐酸莫西沙星滴耳剂及其制备方法
RU2595837C2 (ru) * 2014-09-29 2016-08-27 Открытое Акционерное Общество "Татхимфармпрепараты" Состав и способ получения глазных капель
TWI713618B (zh) * 2015-10-29 2020-12-21 日商帝化製藥股份有限公司 外用劑
US12042500B2 (en) * 2018-04-03 2024-07-23 Hyderabad Eye Research Foundation Mucoadhesive drug delivery system for ocular administration of fluoroquinolone antibiotics
IT201900005280A1 (it) * 2019-04-05 2020-10-05 Ntc S R L Composizione otologica
CA3182196A1 (en) * 2020-06-10 2021-12-16 Anthony Sampietro Compositions and uses in method for post-operative ocular care
CN116270662A (zh) * 2021-12-03 2023-06-23 苏州欧康维视生物科技有限公司 盐酸莫西沙星地塞米松磷酸钠滴眼液
KR102656260B1 (ko) 2022-10-14 2024-04-09 주식회사태준제약 목시플록사신을 포함하는 안과용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223493A (en) 1984-12-28 1993-06-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
US4910225A (en) * 1988-01-27 1990-03-20 Senju Pharmaceutical Co., Ltd. Locally administrable therapeutic composition for inflammatory disease
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
WO1990001933A1 (en) * 1988-08-26 1990-03-08 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
JPH03109236A (ja) * 1989-09-22 1991-05-09 Hoya Corp 半導体超微粒子分散ガラスの製造方法
JPH085779B2 (ja) * 1989-09-22 1996-01-24 杏林製薬株式会社 フレロキサシン点眼液
TW209865B (OSRAM) * 1992-01-10 1993-07-21 Bayer Ag
JP3337218B2 (ja) 1992-05-06 2002-10-21 アルコン ラボラトリーズ，インコーポレイテッド 眼科用組成物におけるホウ酸塩−ポリオール複合体の使用
DE4424369A1 (de) * 1994-07-11 1996-01-18 Bayer Ag Pyrido[3,2,1.i,j][3,1]benzoxazinderivate
JPH0892241A (ja) * 1994-09-22 1996-04-09 Ss Pharmaceut Co Ltd ５−ヒドラジノキノロンカルボン酸誘導体及びこれを有効成分とする抗菌剤
US5631287A (en) 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
CA2199294C (en) * 1995-06-06 2000-09-19 Shivaji Purwar Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions
JP3290914B2 (ja) * 1997-03-17 2002-06-10 参天製薬株式会社 眼組織におけるキノロン系抗菌剤の定量装置
IL134591A0 (en) * 1997-09-25 2001-04-30 Bayer Ag Medicament formulation with a controlled release of an active agent
HUP0103667A3 (en) 1998-09-23 2007-10-29 Unilever Nv Oral care compositions and use of metal complexes for producing of such compositions
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
US20020001617A1 (en) * 2000-05-26 2002-01-03 Chang-Hyun Lee Rapidly disintegrating tablet and process for the manufacture thereof

Also Published As

Publication number Publication date
DE69943287D1 (de) 2011-04-28
HK1059572A1 (en) 2004-07-09
CY1115916T1 (el) 2017-01-25
HK1150756A1 (en) 2012-01-13
DE69912972D1 (de) 2003-12-24
EP2269602B1 (en) 2014-11-19
EP1384478A1 (en) 2004-01-28
CA2342211A1 (en) 2000-04-06
BRPI9914151B8 (OSRAM) 2021-05-25
ES2526521T3 (es) 2015-01-13
JP2002525317A (ja) 2002-08-13
TWI222361B (en) 2004-10-21
HK1038691B (en) 2004-04-23
CY1111404T1 (el) 2015-08-05
EP1384478B1 (en) 2011-03-16
PT2269602E (pt) 2014-12-29
ES2519190T3 (es) 2014-11-06
CA2342211C (en) 2009-05-26
BR9914151A (pt) 2001-06-26
EP2301541B1 (en) 2014-08-20
AR020661A1 (es) 2002-05-22
EP2796138B1 (en) 2016-08-17
WO2000018386A3 (en) 2000-06-08
EP2796138A1 (en) 2014-10-29
EP1117401B1 (en) 2003-11-19
CN1650863A (zh) 2005-08-10
PT2301541E (pt) 2014-10-29
BRPI9914151B1 (pt) 2017-10-03
JP2013018799A (ja) 2013-01-31
HK1150769A1 (en) 2012-01-13
CN1320035A (zh) 2001-10-31
ATE501732T1 (de) 2011-04-15
CA2774207A1 (en) 2000-04-06
WO2000018386A2 (en) 2000-04-06
DK2301541T3 (da) 2014-09-01
ES2207307T3 (es) 2004-05-16
AU762827B2 (en) 2003-07-03
DK2796138T3 (en) 2016-12-05
CY1115759T1 (el) 2017-01-25
ES2602956T3 (es) 2017-02-23
TR200100883T2 (tr) 2001-10-22
AU1310100A (en) 2000-04-17
EP1117401A2 (en) 2001-07-25
JP5563041B2 (ja) 2014-07-30
JP2009007375A (ja) 2009-01-15
JP2014144982A (ja) 2014-08-14
ATE254458T1 (de) 2003-12-15
PT1117401E (pt) 2004-03-31
EP2269602A1 (en) 2011-01-05
CN100374114C (zh) 2008-03-12
HK1038691A1 (en) 2002-03-28
JP2012067141A (ja) 2012-04-05
KR20010075138A (ko) 2001-08-09
DK1384478T3 (da) 2011-05-23
PT2796138T (pt) 2016-09-22
DE69912972T2 (de) 2004-04-22
KR101463243B1 (ko) 2014-12-17
DK2269602T3 (en) 2014-12-15
PT1384478E (pt) 2011-05-12
EP2301541A1 (en) 2011-03-30
CN1184968C (zh) 2005-01-19
DK1117401T3 (da) 2004-02-23
CA2659064A1 (en) 2000-04-06
AR081393A2 (es) 2012-08-29

Similar Documents

Publication Publication Date Title
TR200704370T2 (tr) Göz, kulak ve burun tedavisi için antibiyotik bileşimler
WO2000018388A3 (en) Antibiotic compositions for treatment of the eye, ear and nose
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
BR0015836A (pt) Cristal de 4-carboxiamino-2-etil-1,2,3,4-tetra-hidroquinolina como inibidor de cetp
DE69926806D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
WO1996032003A3 (en) Tetrahydroimidazopyridoindolediones and their use as medicaments
BR0014203A (pt) Formulações de suspensão tópicas contendo ciprofloxacina e dexametasona
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
AU3572300A (en) Liquid crystal compounds
DE69429524D1 (de) Aminocyclohexylester und ihre anwendung
IT1285770B1 (it) Composti corticoidei
HK1038692A1 (zh) 治疗眼、耳、鼻病症的抗生素合成剂
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
BRPI0017528B8 (pt) uso de uma composição contendo sal de cetotifeno
NO971625L (no) Nye peptider med immunomodulatoriske effekter
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
NZ500300A (en) Compositions containing N-(3,4-dimethoxycinnamoyl) anthranilic acid for the treatment of excessive proliferation of retinal pigment epithelial cells
AU7027100A (en) Novel compounds
BR9900559A (pt) Composição de vidro de tipo sìlico-sodo-cálcico.
AU4714297A (en) Metalloproteinase inhibitors
DE69931784D1 (de) Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung
BR9813634A (pt) "abridores de canal de potássio"
AU2001261748A1 (en) Antibiotic compositions for treatment of the eye, ear and nose
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
PL355113A1 (en) Novel fusidic acid derivatives